Table 1.
Characteristics | All patients | Cohort 1 | Cohort 2 |
---|---|---|---|
Median age (range), y | 51.5 (26-60) | 52 (29-60) | 44 (26-50) |
Race | |||
White | 6 | 5 | 1 |
Black | 2 | 1 | 1 |
Other | 2 | 1 | 1 |
Ethnicity | |||
Hispanic or Latino | 3 | 2 | 1 |
Non-Hispanic or Latino | 7 | 5 | 2 |
Median BMI (range), kg/m2 | 26.9 (18.7-47.9) | 24.3 (18.7-47.9) | 32.1 (27.0-37.3) |
FIGO clinical stage | |||
IB1 | 3 | 2 | 1 |
IB2 | 2 | 2 | 0 |
IIB | 2 | 2 | 0 |
IIIB | 2 | 1 | 1 |
IVA | 1 | 0 | 1 |
Lymph node status | |||
Positive | 4 | 2 | 2 |
Negative | 5 | 4 | 1 |
Missing | 1 | 1 | 0 |
Cell type | |||
Squamous | 4 | 3 | 1 |
Adenocarcinoma | 6 | 4 | 2 |
Tumor grade | |||
1 | 4 | 4 | 0 |
2 | 3 | 2 | 1 |
3 | 3 | 1 | 2 |
Median tumor diameter, (range), cm | 5.4 (3.8-6.4) | 5.6 (3.8-6.4) | 5.2 (4.5-6.0) |
HPV status | |||
HPV16 | 7 | 5 | 2 |
HPV18 | 3 | 2 | 1 |
HPV16 and HPV18 | 0 | 0 | 0 |
Abbreviations: BMI = body mass index; FIGO = Federation of Gynecology and Obstetrics; HPV = human papillomavirus.